Citation: Hj. Prochaska et al., INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 LONG TERMINAL REPEAT-DRIVEN TRANSCRIPTION BY AN IN-VIVO METABOLITE OF OLTIPRAZ - IMPLICATIONS FOR ANTIRETROVIRAL THERAPY, Biochemical and biophysical research communications, 221(3), 1996, pp. 548-553